The effect of treatment with fenofibrate on the risk profile of patients with metabolic syndrome and mixed dyslipidemia treated on an outpatient basis

Abstract

The study has shown that patients with metabolic syndrome and typical dyslipidemia treated on an outpatient basis by GP or specialists are those whose anamneses include IHD or diabetes and who are very often indicated for combined statin-fibrate therapy.

Keywords

• effect
• treatment
• fenofibrate
• profile
• patients
• metabolic
• syndrome
• mixed
• dyslipidemia
• treated
• outpatient
• basis